Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Brand name: Tramadol (AN) TM
Active ingredients: tramadol
What it is used for
Relief of moderate to severe pain.
How to take it
The way to take this medicine is: Intramuscular. This medicine is given through a needle inserted into the muscle beneath the skin.
- Store below 30 degrees Celsius
- Protect from Light
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Ampoule containing a transparent, colourless or slightly yellowish solution
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March 1, 2021. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient tramadol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
Top results
Neuropathic pain: current definition and review of drug treatment - Australian Prescriber
Neuropathic pain is relatively common and often poorly treated
Read more on Australian Prescriber website
Opioids - Alcohol and Drug Foundation
Opioids include any drug that acts on opioid receptors in the brain, and any natural or synthetic drugs that are derived from or related to the opium poppy.
Read more on Alcohol and Drug Foundation website
Drug Wheel - Alcohol and Drug Foundation
The Drug Wheel is a classification model that groups different types of drugs based on the effect they have on the body. The updated version of the Drug Wheel has seven categories.
Read more on Alcohol and Drug Foundation website
Medicines and Procedures - Pain Management - painHEALTH
Learn about the various types of medicines and procedures that are available that may be able to form part of your musculoskeletal pain management plan
Read more on painHEALTH website
Diabetic neuropathy - Better Health Channel
Diabetes is the most common cause of neuropathy
Read more on Better Health Channel website
Treatment of fibromyalgia - Australian Prescriber
The burden of living with fibromyalgia is higher than with other rheumatic disorders and higher than with most other chronic illnesses
Read more on Australian Prescriber website
Adverse events associated with medium‐ and long‐term use of opioids for chronic non‐cancer pain: an overview of Cochrane Reviews - Els, C - 2017 | Cochrane Library
Read more on Cochrane (Australasian Centre) website
Returning unwanted medicinesto pharmacies: prescribing toreduce waste | Australian Prescriber
The Return Unwanted Medicines Project is a free and safe way for consumers to dispose of unwanted medicines at...
Read more on Australian Prescriber website
Neuropathic pain - myDr
Find out all about neuropathic pain, nerve pain, which is usually described as a shooting, stabbing or burning pain, with myDr.com.au.
Read more on myDr website
Serotonin and noradrenaline reuptake inhibitors for depression - myDr
Venlafaxine, duloxetine and desvenlafaxine are medicines called serotonin and noradrenaline reuptake inhibitors (SNRIs). They are used to treat depression and some anxiety disorders and nerve pain.
Read more on myDr website
Top results
Tapentadol sustained release (Palexia SR) for chronic, severe disabling pain - NPS MedicineWise
A number of trials have been conducted comparing tapentadol SR with placebo and oxycodone CR for moderate-to-severe chronic non-cancer pain
Read more on NPS MedicineWise website
Complex regional pain syndrome - Australian Prescriber
There is little evidence to guide therapy because of the difficulties in studying specific interventions in complex regional pain syndrome
Read more on Australian Prescriber website
Opioid prescribing in dentistry – is there a problem?
Can a prescription from a dentist lead to drug dependence?
Read more on Australian Prescriber website
Treatment of fibromyalgia - Australian Prescriber
The burden of living with fibromyalgia is higher than with other rheumatic disorders and higher than with most other chronic illnesses
Read more on Australian Prescriber website
Neuropathic pain - NPS MedicineWise
Neuropathic pain is caused by damage to the somatosensory nervous system. Find out more about diagnosis and management of this challenging condition.
Read more on NPS MedicineWise website
Adverse events associated with medium‐ and long‐term use of opioids for chronic non‐cancer pain: an overview of Cochrane Reviews - Els, C - 2017 | Cochrane Library
Read more on Cochrane (Australasian Centre) website
Managing obsessive compulsive disorder | Issue 4 | Volume 38 | Australian Prescriber
Unlike obsessive compulsive personality traits or occasional repetitive habits, obsessive compulsive disorder can be highly distressing and associated with...
Read more on Australian Prescriber website
RACGP - Opioid use in chronic non-cancer pain Part 1: Known knowns and known unknowns
Opioids have a critical, time-limited role in our management of acute and terminal pain and an open-ended role in our management of opioid dependency. They also have a use in the management of chronic non-cancer pain. | RACGP
Read more on RACGP - The Royal Australian College of General Practitioners website
Prescribing for patients on dialysis | Issue 1 | Volume 39 | Australian Prescriber
The pharmacokinetics of a drug may be altered in patients with renal impairment who require dialysis.
Read more on Australian Prescriber website
Episode 19: Opioids special #1: Tapering opioids in partnership with patients with chronic non-cancer pain
In this episode Dr Anna Samecki talks with accredited pharmacist Kara Joyce, who has been overseeing the new NPS MedicineWise program on Dementia and changed behaviours: a person-centred approach.
Read more on NPS MedicineWise website
